# Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

NDC: 35573-467
Generic name: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Labeler / Manufacturer: Burel Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20191216
Marketing ended: 20280229
FDA application: ANDA212037

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 5 mg/1
- AMPHETAMINE SULFATE: 5 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 5 mg/1
- DEXTROAMPHETAMINE SULFATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"35573-467"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=35573-467
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcdd2fe2-d0de-4a28-aced-40ac9ce5122d